148 related articles for article (PubMed ID: 12173306)
1. gamma/delta T cells in multiple sclerosis: chemokine and chemokine receptor expression.
Murzenok PP; Matusevicius D; Freedman MS
Clin Immunol; 2002 Jun; 103(3 Pt 1):309-16. PubMed ID: 12173306
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
Teleshova N; Pashenkov M; Huang YM; Söderström M; Kivisäkk P; Kostulas V; Haglund M; Link H
J Neurol; 2002 Jun; 249(6):723-9. PubMed ID: 12111306
[TBL] [Abstract][Full Text] [Related]
3. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
4. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
Sørensen TL; Tani M; Jensen J; Pierce V; Lucchinetti C; Folcik VA; Qin S; Rottman J; Sellebjerg F; Strieter RM; Frederiksen JL; Ransohoff RM
J Clin Invest; 1999 Mar; 103(6):807-15. PubMed ID: 10079101
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
Høglund RA; Hestvik AL; Holmøy T; Maghazachi AA
Hum Immunol; 2011 Feb; 72(2):124-34. PubMed ID: 20977917
[TBL] [Abstract][Full Text] [Related]
6. Expression of chemokine receptors in the different clinical forms of multiple sclerosis.
Martínez-Cáceres EM; Espejo C; Brieva L; Pericot I; Tintoré M; Sáez-Torres I; Montalban X
Mult Scler; 2002 Oct; 8(5):390-5. PubMed ID: 12356205
[TBL] [Abstract][Full Text] [Related]
7. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.
Sørensen TL; Sellebjerg F
Neurology; 2001 Oct; 57(8):1371-6. PubMed ID: 11673573
[TBL] [Abstract][Full Text] [Related]
8. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
9. Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells.
Glatzel A; Wesch D; Schiemann F; Brandt E; Janssen O; Kabelitz D
J Immunol; 2002 May; 168(10):4920-9. PubMed ID: 11994442
[TBL] [Abstract][Full Text] [Related]
10. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
Aggarwal A; Agarwal S; Misra R
Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing-remitting multiple sclerosis.
Wang HY; Matsui M; Araya S; Onai N; Matsushima K; Saida T
J Neuroimmunol; 2002 Dec; 133(1-2):184-92. PubMed ID: 12446021
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis.
Sørensen TL; Roed H; Sellebjerg F
J Neuroimmunol; 2002 Jan; 122(1-2):125-31. PubMed ID: 11777551
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis.
Sindern E; Patzold T; Ossege LM; Gisevius A; Malin JP
J Neuroimmunol; 2002 Oct; 131(1-2):186-90. PubMed ID: 12458051
[TBL] [Abstract][Full Text] [Related]
15. Transendothelial chemotaxis of human alpha/beta and gamma/delta T lymphocytes to chemokines.
Roth SJ; Diacovo TG; Brenner MB; Rosat JP; Buccola J; Morita CT; Springer TA
Eur J Immunol; 1998 Jan; 28(1):104-13. PubMed ID: 9485190
[TBL] [Abstract][Full Text] [Related]
16. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
18. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
[TBL] [Abstract][Full Text] [Related]
19. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.
Mahad DJ; Howell SJ; Woodroofe MN
J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):498-502. PubMed ID: 11909910
[TBL] [Abstract][Full Text] [Related]
20. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines.
Cockwell P; Calderwood JW; Brooks CJ; Chakravorty SJ; Savage CO
Nephrol Dial Transplant; 2002 May; 17(5):734-44. PubMed ID: 11981057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]